Author of

• 25961

  +

  P3.07 - Nursing and Allied Professionals (Not CME Accredited Session) (ID 973)

  • Event: WCLC 2018
  • Type: Poster Viewing in the Exhibit Hall
  • Track:
  • Presentations: 1
  • Moderators:
  • Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall

  • 27548

    +

    P3.07-08 - Pain Management in Lung Cancer (ID 14280)

    12:00 - 13:30  |  Presenting Author(s): Abdallah El Meziane
    • Abstract
    • Slides

    Background
    

    Lung cancer is one of the most prevalent cancers worldwide and pain is its most common symptom. Pain can be brought about by several causes including local invasion of chest structures, metastatic disease or can also be a consequence of treatment. An active multidisciplinary approach is required to manage pain in patients with lung cancer

    a9ded1e5ce5d75814730bb4caaf49419 Method
    

    It is a cross-sectional study of 166 patients with lung cancer. We used the BPI ``Brief pain inventory`` to assess pain prevalence, intensity and impact on quality of life. Adequacy of pain management was evaluated by the Pain Management Index (PMI)

    4c3880bb027f159e801041b1021e88e8 Result
    

    We interwiewed 166 patients with bronchogenic carcinoma, 163 men and 3 women. 116 with adenocarcinoma and 50 with epidermoid carcinoma. 80 (42.2%) of our patients have pain. Among them, 7 report low pain and 73 moderate to severe pain (91%). 149 (89,7%) patients have metastasis. The association between the intensity of pain and metastasis was statisticly significant (p<0,001). 21 patients (26.2%) are treated with antalgic. 18 with the second level and 3 with the third level. The Pain Management Index (PMI) is negative in 63 patients (81.2%). There is also a stastically significant correlation between the intensity of pain and the degradation of each quality of life parameter.

    8eea62084ca7e541d918e823422bd82e Conclusion
    

    Pain management still remains a challenge. This deficiency is due to the inadequate medical training and the unavailability of most third level of analgesics in ambulatory prescription.

    6f8b794f3246b0c1e1780bb4d4d5dc53

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.